Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Human stem cell derived oligodendrocytes for treatment of stroke and MS

  • Post author:
  • Post published:November 18, 2025
  • Post category:

Strokes that affect the nerves cells, i.e., “gray matter”, consistently receive the most attention. However, the kind of strokes that affecting the “wiring” of the brain, i.e., “white matter”, cause…

Continue ReadingHuman stem cell derived oligodendrocytes for treatment of stroke and MS

Human Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination

  • Post author:
  • Post published:November 18, 2025
  • Post category:

Multiple sclerosis (MS) is the most common neurologic disease affecting young adults under the age of 40 with the majority of MS patients diagnosed in the second or third decade…

Continue ReadingHuman Embryonic Stem Cells and Remyelination in a Viral Model of Demyelination

Embryonic stem cell-derived thymic epithelial cells

  • Post author:
  • Post published:November 18, 2025
  • Post category:

The function of the immune system throughout life is essential for protection from infections and cancer. T lymphocytes are white blood cells that choreograph the multiple responses that the body…

Continue ReadingEmbryonic stem cell-derived thymic epithelial cells

Genetic modification of the human genome to resist HIV-1 infection and/or disease progression

  • Post author:
  • Post published:November 18, 2025
  • Post category:

The proposed studies describe the genetic approaches utilizing human embryonic stem cells to suppress and/or eliminate the expression of the human protein CCR5. CCR5 is found on the surface of…

Continue ReadingGenetic modification of the human genome to resist HIV-1 infection and/or disease progression

HPSC based therapy for HIV disease using RNAi to CCR5.

  • Post author:
  • Post published:November 18, 2025
  • Post category:

RNA interference is a naturally occurring means to block the function of genes in our body. We propose that RNA interference can be used to block HIV-1 infection and its…

Continue ReadingHPSC based therapy for HIV disease using RNAi to CCR5.

ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS

  • Post author:
  • Post published:November 18, 2025
  • Post category:

Some years ago it was discovered that patients homozygous for a natural mutation (the Δ32 mutation) in the CCR5 gene are generally resistant to HIV infection by blocking virus entry…

Continue ReadingZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS

TRX103 for prevention of GvHD in patients receiving HLA mismatched HSCT for the treatment of hematologic malignancies

  • Post author:
  • Post published:November 16, 2025
  • Post category:

Continue ReadingTRX103 for prevention of GvHD in patients receiving HLA mismatched HSCT for the treatment of hematologic malignancies

A phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus

  • Post author:
  • Post published:November 16, 2025
  • Post category:

Continue ReadingA phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus

Anti-HIV duoCAR-T cell therapy for HIV infection

  • Post author:
  • Post published:November 16, 2025
  • Post category:

The University of California San Francisco (UCSF) is conducting a clinical trial that modifies a patient's own immune cells in order to treat and potentially cure HIV.  Current treatment of…

Continue ReadingAnti-HIV duoCAR-T cell therapy for HIV infection

A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

  • Post author:
  • Post published:November 16, 2025
  • Post category:

Leukocyte Adhesion Deficiency-I (LAD-I) is a rare pediatric disease caused by a mutation in a specific gene that affects the body's ability to combat infections.  As a result, infants with…

Continue ReadingA Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us